APA

Macdonald F. R., Peel J. E., Jones H. B., Mayers R. M., Westgate L., Whaley J. M. & Poucher S. M. (20110603). The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats. : Diabetes, obesity & metabolism.

Chicago

Macdonald F R, Peel J E, Jones H B, Mayers R M, Westgate L, Whaley J M and Poucher S M. 20110603. The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats. : Diabetes, obesity & metabolism.

Harvard

Macdonald F. R., Peel J. E., Jones H. B., Mayers R. M., Westgate L., Whaley J. M. and Poucher S. M. (20110603). The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats. : Diabetes, obesity & metabolism.

MLA

Macdonald F R, Peel J E, Jones H B, Mayers R M, Westgate L, Whaley J M and Poucher S M. The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats. : Diabetes, obesity & metabolism. 20110603.